Conventional vs. Sensor Guided Soft Tissue Balancing in TKA RCT

August 31, 2022 updated by: Mitch Winemaker, Hamilton Health Sciences Corporation

Randomized Controlled Trial of Sensor Guided Knee Balancing Compared to Standard Balancing Technique in Total Knee Arthroplasty

To ensure a successful outcome after total knee replacement (TKR) soft tissue balance and proper implant position are very important during the surgical procedure. Soft tissues are structures in the knee including ligaments, muscles, tendons, and menisci that stabilize and cushion the knee joint. Lack of proper soft tissue balance or imprecise implant positioning may result in knee stiffness, pain, instability and limited range of motion (ROM). This may result in implant failure and the need for revision surgery. As part of standard practice orthopedic surgeons use a manual knee balancer device to help guide soft tissue balancing to achieve optimal knee balance. New sensor-assisted technology can provide surgeons with measurable information to help achieve soft tissue balancing, providing surgeons with immediate visual feedback during the surgery. This feedback, transmitted wirelessly by the sensor, gives surgeons electronic information on soft tissue balance and implant position.The purpose of this study is to determine if a sensor guided soft tissue balancing device (Verasense) is more effective at balancing the knee during surgery as compared to standard soft tissue balancing performed with a manual balancer device.

Study Overview

Detailed Description

The study is that of a prospective double-blind randomized controlled trial of patients presenting for elective primary TKR to compare the outcomes of TKR using conventional soft tissue balancing with a tensiometer device versus augmenting the soft tissue balancing with the OrthoSensor VerasenseTM sensor device. The primary outcome will be rate of unbalanced TKRs based on the quantitative Verasense definition of a well balanced knee defined as a mediolateral intercompartmental loading difference of ≤15 pounds through ROM. Secondary outcomes include differences in clinical outcome scores and patient satisfaction among sensor guided cases and controls.

Patients will be randomized to receive TKR with the Triathlon total knee system (Stryker) in the case and control group according to: (1) control group with standard balancing techniques used and sensor data obtained in blinded fashion and not used to balance the TKR implant, (2) experimental case group with sensor guided balancing where sensor data is used to balance the TKR within defined parameters.

Study Type

Interventional

Enrollment (Actual)

184

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Ontario
      • Hamilton, Ontario, Canada, L8V 1C3
        • Hamilton Health Sciences Juravinski Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Patients scheduled to undergo elective primary unilateral TKR for a diagnosis of osteoarthritis to be performed at the study site by the primary investigators
  • Willingness and ability to give informed consent.

Exclusion Criteria:

  • Inflammatory arthropathy
  • Ligament insufficiencies
  • Contraindications to posterior cruciate retaining TKR including: deformity >15 degrees or fixed-flexion contracture >15 degrees
  • Previous high tibial osteotomy
  • Scheduled to undergo sequential bilateral TKR under one anesthetic
  • Scheduled to undergo revision TKR surgery
  • Neuromuscular disorder limiting mobility or ability to comply with physiotherapy
  • Previous recurrent deep knee infection
  • Major bone loss requiring structural bone graft or augmented components
  • Functionally limiting peripheral vascular disease
  • Patients receiving associated worker's compensation benefits (WSIB)
  • Ethanol/drug abuse/psychiatric disorder
  • Inability or unwillingness to give written informed consent to participate

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Standard Soft Tissue Balancing
In the control group where the sensor device is not used in optimization of knee balance and alignment, definitive implants will be cemented in place and the sensor trial inserted using a thickness based on prior standard bearing insert trialing. Peak load data will be captured intraoperatively through full ROM. Custom shims will be affixed to the sensor to replicate thickness of the standard trial. The knee will then be cycled and loads recorded in the medial and lateral compartments at 10, 45 and 90 degrees of flexion. The surgeon will be blinded to the sensor output and the system will be located outside of their visual field.
Primary TKR with soft tissue balancing with a standard of care manual tensiometer device.
Other Names:
  • Triathlon (Stryker, Mahwah, NJ)
Experimental: Sensor Guided Soft Tissue Balancing
In the experimental group where the sensor device is used to optimize balance and alignment, the sensor trial will be inserted and tibial baseplate rotated until medial and lateral femoral contact points are parallel on the sensor output. Quantitative balance is defined as a mediolateral intercompartmental loading difference of ≤15 pounds. Flexion balance is achieved when femoral contact point position is within the midposterior third of the tibial insert and intercompartmental loads are balanced. Loads in the medial and lateral compartments are recorded at 10, 45 and 90 degrees. If compartment loads differ by >15 lbs between compartments, unbalanced, further soft tissue release/bone resection will be done to achieve a side to side compartment pressure difference of <15 lbs through ROM.
Primary TKR with soft tissue balancing with a sensor guided device.
Other Names:
  • Triathlon (Stryker, Mahwah, NJ)
  • Verasense (OrthoSensor Inc., Dania Beach, FL)

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Rate of Unbalanced TKRs
Time Frame: Intraoperative at end of procedure prior to wound closure
The rate of unbalanced TKRs will be assessed based on the Verasense sensor device quantitative definition of a well balanced knee. A well balanced knee is defined as having a mediolateral intercompartmental loading difference of ≤15 pounds through ROM [Gustke et al., Walker et al].
Intraoperative at end of procedure prior to wound closure

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Knee Society Score
Time Frame: Preoperative, 6 weeks, 6 months and 1 year postoperative
Overall clinical function as measured by Knee Society Score
Preoperative, 6 weeks, 6 months and 1 year postoperative
Oxford Knee Score
Time Frame: Preoperative, 6 weeks, 6 months and 1 year postoperative
Subjective function as measured by Oxford Knee Score patient report outcome measure
Preoperative, 6 weeks, 6 months and 1 year postoperative
Patient satisfaction
Time Frame: 1 year postoperative
Patient satisfaction with total knee replacement; likert scale
1 year postoperative
Clinical knee function: varus/valgus alignment
Time Frame: Preoperative, intraoperative, 6 weeks, 6 months and 1 year postoperative
Assessment of clinical knee function
Preoperative, intraoperative, 6 weeks, 6 months and 1 year postoperative
Clinical knee function: anteroposterior stability
Time Frame: Preoperative, intraoperative, 6 weeks, 6 months and 1 year postoperative
Assessment of clinical knee function
Preoperative, intraoperative, 6 weeks, 6 months and 1 year postoperative
Clinical knee function: extension lag
Time Frame: Preoperative, intraoperative, 6 weeks, 6 months and 1 year postoperative
Assessment of clinical knee function
Preoperative, intraoperative, 6 weeks, 6 months and 1 year postoperative
Clinical knee function: anatomic alignment
Time Frame: Preoperative, intraoperative, 6 weeks, 6 months and 1 year postoperative
Assessment of clinical knee function
Preoperative, intraoperative, 6 weeks, 6 months and 1 year postoperative
Clinical knee function: knee ROM
Time Frame: Preoperative, intraoperative, 6 weeks, 6 months and 1 year postoperative
Assessment of clinical knee function
Preoperative, intraoperative, 6 weeks, 6 months and 1 year postoperative

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Mitch Winemaker, MD, FRCSC, Hamilton Health Sciences Corporation

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

February 1, 2017

Primary Completion (Actual)

May 15, 2018

Study Completion (Actual)

September 3, 2020

Study Registration Dates

First Submitted

November 22, 2016

First Submitted That Met QC Criteria

November 23, 2016

First Posted (Estimate)

November 29, 2016

Study Record Updates

Last Update Posted (Actual)

September 1, 2022

Last Update Submitted That Met QC Criteria

August 31, 2022

Last Verified

August 1, 2022

More Information

Terms related to this study

Other Study ID Numbers

  • HAGRP01

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Total Knee Arthroplasty

Clinical Trials on Standard Soft Tissue Balancing

3
Subscribe